Increased price transparency in health care - Challenges and potential effects

New England Journal of Medicine

Volumn 364, Issue 10, 2011, Pages 891-894

  Sinaiko, Anna D ^a   Rosenthal, Meredith B ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONSUMER ATTITUDE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH INSURANCE; HUMAN; INFORMATION DISSEMINATION; MEDICAL FEE; PRIORITY JOURNAL; SHORT SURVEY; UNITED STATES;

EID: 79952423711     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1100041     Document Type: Short Survey

References (5)

1. Tu HA, Lauer JR. Impact of health care price transparency on price variation: the New Hampshire experience. Issue brief no. 128. Washington, DC: Center for Studying Health System Change, 2009.
2. Massachusetts Division of Healthcare Finance and Policy. Measuring healthcare quality and cost in Massachusetts. (http:// www.mass.gov/Eeohhs2/ docs/dhcfp/r/pubs/09/measuring-hc-quality-cost-mass-nov-09.pdf.)
3. Waber RL, Shiv B, Carmon Z, Ariely D. Commercial features of placebo and therapeutic efficacy. JAMA 2008;299:1016-7. (Pubitemid 351347074)
4. Sinaiko AD. How do quality information and cost affect patient choice of provider in a tiered network setting? Results from a survey. Health Serv Res 2010 December 9 (Epub ahead of print).
5. Hsu J, Fung V, Price M, et al. Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs. JAMA 2008;299:1929-36. (Pubitemid 351574923)